<?xml version="1.0" encoding="utf-8"?> 

<rss version="2.0"> 

<channel>

<title>LexisNexis&#174; Mealey's&#8482; Hormone Replacement Therapy Legal News</title>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

<description>Headline Hormone Replacement Therapy Legal News from LexisNexis&#174;</description>

<language>en-us</language>

<image>

<title>LexisNexis&#174; Headline Hormone Replacement Therapy Legal News</title>

<url>http://www.lexisnexis.com/mealeys/images/lexismealeyslogo.gif</url>

<width>130</width> 
  
<height>29</height>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

</image> 

<copyright>Copyright 2009</copyright>

<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Jury: Prempro Proximately Caused Breast Cancer; Woman Deserves $3.7 Million</title>
<description>
<![CDATA[PHILADELPHIA - A Pennsylvania Court of Common Pleas jury on Sept. 25 found that Prempro was a proximate cause of an Illinois woman's development of breast cancer and that she deserves $3.7 million in compensatory damages (Connie Barton v. Wyeth Pharmaceuticals Inc., Case No. 040406301, Pa. Comm. Pls., Philadelphia Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Parties In 5 N.J. HRT Cases Ordered To Submit More Choice-Of-Law Briefs</title>
<description>
<![CDATA[NEW BRUNSWICK, N.J. - The New Jersey judge presiding over the state's hormone replacement therapy mass tort litigation on Sept. 22 ordered parties in five cases where Wyeth has moved for summary judgment based on the statute of limitations to file additional briefing as to choice-of-law issues (In re: HRT Litigation, Case No. 266, N.J. Super., Middlesex Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>JPMDL Centralizes Yaz/Yasmin Cases In Southern District Of Illinois</title>
<description>
<![CDATA[WASHINGTON, D.C. - The Judicial Panel on Multidistrict Litigation on Oct.1 created a multidistrict litigation for federal lawsuits involving injuries allegedly caused by the use of Yaz and Yasmin in the U.S. District Court for the Southern District of Illinois before Judge David Herndon (In re: Yaz/Yasmin Products Liability Litigation, MDL No. 2100, JPMDL). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Pennsylvania Judge Coordinates State Court Cases Involving Yaz, Yasmin And Ocella</title>
<description>
<![CDATA[PHILADELPHIA - A Pennsylvania state court judge on Sept. 16 signed an order coordinating proceedings in 14 cases filed in the Philadelphia County Court of Common Pleas by plaintiffs who allegedly sustained injuries as a result of using Bayer Corp.'s Yaz, Yasmin and Ocella birth control pills (In re: Yaz/Yasmin/Ocella Litigation, Sept. Term 2009, Case No. 1307, Pa. Comm. Pls., Philadelphia Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>2 Union Health Funds Say Bayer Unlawfully Marketed Yaz To Increase Sales</title>
<description>
<![CDATA[PHILADELPHIA - Two health funds for Philadelphia workers on Oct. 5 filed a class action suit in federal court against the makers of Yaz, alleging that the companies fraudulently and unlawfully marketed the oral contraceptive by overstating its safety and efficacy to increase sales (Philadelphia Firefighters Union Local No. 22 Health and Welfare Fund, et al. v. Bayer Healthcare Pharmaceuticals Inc., et al., No. 09-cv-4567, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Couple's Complaint Lacks Required Specificity, NuvaRing Maker Argues</title>
<description>
<![CDATA[ST. LOUIS - The makers of NuvaRing say in a Sept. 25 motion for judgment on the pleadings that a Wisconsin couple's lawsuit should be dismissed because the complaint fails to include any factual allegations to support a cause of action as required by the U.S. Supreme Court's rulings in Bell Atlantic v. Twombly (550 U.S. 544 [2007]) and Ashcroft v. Iqdal (129 S. Ct. 1937 [2009]) (In re: NuvaRing Products Liability Litigation, MDL No. 1964, Case No. 08-md-1964; Kimberly Bryan, et al. v. Organon USA Inc., et al., No. 09-cv-1021-RWS, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Organon USA Says Complaint Fails To Meet Federal Pleading Requirements</title>
<description>
<![CDATA[ST. LOUIS - A North Carolina woman's NuvaRing products liability lawsuit should be dismissed, one of the makers of the contraceptive says in a Sept. 28 motion, because she fails to provide facts to support her claims and her fraud claims are not pleaded with particularity as required by Federal Rule of Civil Procedure 9 (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, Stephanie Holladay Dillon v. Organon USA Inc., et al., No. 09-cv-1608-RWS, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>New Jersey Ortho Evra Trial Rescheduled For May 2010</title>
<description>
<![CDATA[NEW BRUNSWICK, N.J. - The first bellwether trial in New Jersey's Ortho Evra mass tort proceeding has been rescheduled from April 2010 until May, according to a case management order entered Sept. 30 by the presiding New Jersey judge (In re: Ortho Evra Birth Control Patch Litigation, Case No. 275; Karlin Herring v. Johnson &amp; Johnson, No. L-5787-07, N.J. Super., Middlesex Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Allergan Wants Court To Find Off-Label Promotion Rules Are Unconstitutional</title>
<description>
<![CDATA[WASHINGTON, D.C. - Already under federal investigation for the off-label marketing of Botox, manufacturer Allergan Inc. on Oct. 1 asked a federal court to declare that federal regulations barring promotion of off-label uses of drugs are an unconstitutional violation of its First Amendment free speech rights (Allergan, Inc. v. United States of America, et al., No. 09-1879, D. D.C.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Study: HRT Use May Increase Risk Of Death From Lung Cancer</title>
<description>
<![CDATA[NEW YORK - The use of combination hormone replacement therapy may increase the risk of death from lung cancer in postmenopausal women using the drugs who already have the disease, according to a study published in the Sept. 20 online version of The Lancet. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 11%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>FDA Warns Bayer Over Testing Practices At German Plant</title>
<description>
<![CDATA[ROCKVILLE, Md. - The Food and Drug Administration on Sept. 15 issued a warning letter to the maker of the Yaz and Yasmin birth control pills over testing problems the agency witnessed during a March visit to the manufacturer's Berghamen, Germany, plant. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 11 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Court: Minnesota's Statute Of Limitations Applies To Nonresident's HRT Lawsuit</title>
<description>
<![CDATA[MINNEAPOLIS - Minnesota's six-year statute of limitations is applicable to a Pennsylvania woman's lawsuit alleging that her use of hormone replacement therapies made by Wyeth and Greenstone Ltd. caused her to develop breast cancer because the actions giving rise to her complaint arose before Aug. 1, 2004, the state's high court ruled Sept. 3 (Rachel Fleeger v. Wyeth, et al., No. A08-2124, Minn. Sup.; 2009 Minn. LEXIS 593; See March 2009, Page 9). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Prempro Plaintiff Says Expert's Use Of Differential Diagnosis Was Reliable</title>
<description>
<![CDATA[ST. LOUIS - A woman who was awarded $2.75 million in compensatory damages after a federal jury found that her use of hormone replacement therapies made by Wyeth and Pfizer Inc. subsidiary Pharmacia &amp; Upjohn caused her to develop breast cancer says in an Aug. 25 letter brief to the Eighth Circuit U.S. Court of Appeals that a ruling by the Viagra multidistrict litigation judge regarding the use of differential diagnosis should not be considered because her expert properly employed the methodology (Donna Scroggin v. Wyeth, et al., Nos. 08-2555, 08-2711, 08-2713, 8th Cir.; See related story in this issue). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>HRT Makers Submit Viagra Causation Ruling To 8th Circuit</title>
<description>
<![CDATA[ST. LOUIS - The manufacturers of Premarin and Provera, who are seeking reversal of a $2.75 million compensatory damages verdict, on Aug. 21 submitted to the Eighth Circuit U.S. Court of Appeals a recent ruling from the Viagra multidistrict litigation judge to support their argument that differential diagnosis is an unreliable methodology for determining specific causation (Donna Scroggin v. Wyeth, et al., Nos. 08-2555, 08-2711, 08-2713, 8th Cir.; See April 2009, Page 6). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Bayer Agrees That Yaz/Yasmin MDL Should Be Located In Ohio</title>
<description>
<![CDATA[WASHINGTON, D.C. - The maker of Yaz and Yasmin says in an Aug. 21 brief that it agrees with plaintiffs that cases involving injuries allegedly caused by the birth control pills should be centralized by the Judicial Panel on Multidistrict Litigation and that U.S. Judge James Carr of the Northern District of Ohio should preside over the proceedings (In re: Yaz/Yasmin Products Liability Litigation, MDL No. 2100, JPMDL; See August 2009, Page 4). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Missouri Woman Says Use Of Bayer's Birth Control Caused Deep Vein Thrombosis</title>
<description>
<![CDATA[ST. LOUIS - A Missouri woman on Sept. 2 filed suit in federal court against the makers of Yaz and Yasmin, alleging that her use of the oral contraceptives for less than one year caused her to suffer deep vein thrombosis (DVT) in both of her legs in March 2006 (Anna Lorenz v. Bayer Corp., et al., No. 09-cv-1399, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Ohio Couple Says Birth Control Pills Caused Woman's Gallstones</title>
<description>
<![CDATA[NEW YORK - An Ohio couple says in a Sept. 3 lawsuit filed in New York federal court that the woman's use of Yaz and Yasmin caused her to develop gallstones that necessitated the removal of her gallbladder in September 2007 and that the makers of the birth control pills failed to adequately warn about the drugs' risks (Ambur Tiller, et al. v. Bayer Pharmaceuticals Corp., et al., No. 09-3838, E.D. N.Y.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Appeal Of Ruling Denying Motion To Dismiss Is Unnecessary, Plaintiffs Say</title>
<description>
<![CDATA[ST. LOUIS - Plaintiffs in the NuvaRing multidistrict litigation say in an Aug. 26 brief that the manufacturers' request to certify for appeal the order denying their motion to dismiss the master complaint should be denied because the ruling does not involve a controlling issue of law and would not advance the termination of the litigation (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.; See related story in this issue). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>NuvaRing Makers Seek To Certify Order Denying Dismissal Of Master Complaint</title>
<description>
<![CDATA[ST. LOUIS - Organon Pharmaceuticals Inc. on Aug. 17 asked the federal judge presiding over the NuvaRing multidistrict litigation to certify for interlocutory appeal his recent order denying its motion to dismiss the plaintiff's master complaint for the Eighth Circuit U.S. Court of Appeals to determine if master complaints are entitled to substantial leniency and immune from heightened pleading requirements (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.; See August 2009, Page 14). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Current Discovery Process Is Efficient, NuvaRing Makers Tell MDL Court</title>
<description>
<![CDATA[ST. LOUIS - An order compelling the manufacturers of NuvaRing to provide documents to the plaintiffs every 30 days is unnecessary, the contraceptive makers say in a Sept. 8 response brief filed in the NuvaRing products liability multidistrict litigation court in the U.S. District Court for the Eastern District of Missouri, because every effort is being made to efficiently and quickly produce the voluminous amount of documents the plaintiffs are requesting (In re: NuvaRing Products Liability Litigation, MDL No. 1964, Case No. 08-md-1964, E.D. Mo.; See related story in this issue). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Plaintiffs In NuvaRing MDL Ask For Accelerated Document Production</title>
<description>
<![CDATA[ST. LOUIS - Plaintiffs in the NuvaRing products liability multidistrict litigation say in an Aug. 24 motion to compel that the manufacturers should be required to produce a minimum number of documents every 30 days because the defendant companies' current system of producing documents is "simply not workable" and has resulted in significant delay in the process of conducting other discovery (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>

<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Yaz / Yasmin Plaintiffs Seek Creation Of MDL In Northern District Of Ohio</title>
<description>
<![CDATA[WASHINGTON, D.C. - Counsel representing plaintiffs who claim that they suffered injuries as a result of using Yaz or Yasmin oral contraceptive pills on July 24 filed a petition before the Judicial Panel on Multidistrict Litigation to centralize their lawsuits before U.S. Judge James G. Carr of the Northern District of Ohio (In re: Yaz/Yasmin Products liability Litigation, MDL No. 2100, JPMDL). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Federal Judge Stays Proceedings In 5 California Yaz / Yasmin Suits</title>
<description>
<![CDATA[OAKLAND, Calif. - A federal judge in California on Aug. 5 stayed proceedings in five cases involving injuries allegedly caused by the use of Bayer Corp.'s Yaz and/or Yasmin birth control pills pending a decision from the Judicial Panel on Multidistrict Litigation on whether to centralize the cases (Bridget Tanner, et al. v. Bayer Corp., et al., No. C 09-1558; Stephanie Ivey v. Bayer Corp. et al., No. C 09-1904; Dawn Voss v. Bayer Corp., et al., No. C 09-0905; Tamara Jirbi v. Bayer Corp., et al., No. C 09-2416; Bieanica White v. Bayer Corp., et al., No. C 09-2417, N.D. Calif.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Yaz Complaint Says Decedent Died Of Lung Blood Clots</title>
<description>
<![CDATA[COUNCIL BLUFFS, Iowa - A complaint was filed July 22 in an Iowa federal court alleging that a woman who used Yaz birth control for nine months developed pulmonary emboli and died (Jill Fender, et al. v. Bayer Corporation, et al., No. 09-24, S.D. Iowa, W. Div.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Complaint Alleges Yaz Caused Deep Vein Thrombosis</title>
<description>
<![CDATA[BENTON, Ill. - An Illinois woman on July 24 filed a complaint in Illinois federal court, alleging that her use of Yaz birth control pills caused her to develop deep vein thrombosis (Brenda Hill v. Bayer Corporation, et al., No. 09-567, S.D. Ill., Benton Div.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Texas Woman Says Yasmin Use Resulted In Deep Vein Thrombosis, Pulmonary Embolism</title>
<description>
<![CDATA[SHERMAN, Texas - A Texas woman filed a lawsuit in federal court on July 22 against the makers of Yasmin, alleging that her use of the oral contraceptive caused her to suffer a deep vein thrombosis and pulmonary embolism in July 2008 (Alaina Klarquist v. Bayer Corp., et al., No. 09-09-cv-00345-RAS-DDB, E.D. Texas). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Divided Federal Circuit Finds Bayer's Patent For Yasmin Invalid</title>
<description>
<![CDATA[WASHINGTON, D.C. - The Federal Circuit U.S. Court of Appeals on Aug. 5 found Bayer Schering Pharma AG's patent for Yasmin invalid after finding that the advances in the use of drospirenone, the progestin component of the birth control pill, that led to its creation were too obvious for a company to patent (Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals, Inc. v. Barr Laboratories, Inc., No. 2008-1282, Fed. Cir.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Minnesota Appeals Court Affirms Inadequate Causation Rulings In HRT Lawsuit</title>
<description>
<![CDATA[ST. PAUL, Minn. - The Minnesota Court of Appeals on July 21 upheld a trial court judge's decision to award summary judgment to Wyeth after finding that a woman failed to provide sufficient scientific evidence to support her contention that ingesting hormone replacement therapy for nearly 20 years caused her to develop breast cancer, because the judge did not err in concluding that the woman's experts were not qualified and because the experts' specific causation theories were not reliable (Patricia Zandi v. Wyeth, et al., No. A08-1455, Minn. App.; 2009 Minn. App. Unpub. LEXIS 785; See November 2007, Page 4). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Prempro MDL Judge Unseals Documents Concerning Wyeth's Ghostwriting Practices</title>
<description>
<![CDATA[LITTLE ROCK, Ark. - The federal judge presiding over the Prempro multidistrict litigation on July 24 granted requests from the publisher of the Public Library of Science (PLOS) medical journal, the New York Times Co. and the Plaintiffs' Steering Committee (PSC) to unseal documents pertaining to Wyeth's ghostwriting practices (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-CV-1507, E.D. Ark.; See July 2009, Page 4). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Wyeth Calls Motions To De-Designate Ghostwriting Documents A 'Sideshow'</title>
<description>
<![CDATA[LITTLE ROCK, Ark. - Wyeth says in a July 18 opposition brief filed in the federal Prempro multidistrict litigation that it should not be required to defend the confidential status of documents relating to the ghostwriting of medical articles on the safety of hormone replacement therapy because it has not engaged in the practice for five years and that the current requests for release of the information is a "sideshow" intended to pressure the drug company into settling the litigation (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-CV-1507, E.D. Ark.; See July 2009, Page 4). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Judge Says Ruling Finding Prempro Claims Untimely Should Be Affirmed</title>
<description>
<![CDATA[PHILADELPHIA - A Pennsylvania state court judge held July 8 that his previous ruling awarding summary judgment to Wyeth in a Prempro products liability case should be upheld because Pennsylvania law does not require a plaintiff to know of a definitive association between an injury and its possible cause to trigger the statute of limitations (Mildred Edwards, et al. v. Wyeth Pharmaceuticals Inc., et al., No. 060403669, Pa. Comm. Pls., Philadelphia Co.; 2009 Phila. Ct. Com. Pl. LEXIS 133). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 11%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>New Judge Appointed To Preside Over New Jersey HRT Mass Tort</title>
<description>
<![CDATA[TRENTON, N.J. - Middlesex County Superior Court Judge Jessica R. Mayer will replace Judge Jamie Happas in presiding over New Jersey's mass tort proceedings for cases involving injuries allegedly caused by hormone replacement therapy beginning Sept. 1, according to a notice to the bar entered Aug. 7 (In re: HRT Litigation, Case No. 266, N.J. Super., Middlesex Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 11 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 12%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>NuvaRing MDL Judge Denies Makers' Request To Dismiss Master Complaint</title>
<description>
<![CDATA[ST. LOUIS - The federal judge presiding over the NuvaRing products liability multidistrict litigation on Aug. 6 denied the manufacturers' motion to dismiss the plaintiffs' master complaint after finding the filing of the document was intended to act as an administrative tool listing all of the claims in the litigation (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 12 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 13%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>NuvaRing MDL Judge Rejects Manufacturers' Request To Share E-discovery Costs</title>
<description>
<![CDATA[ST. LOUIS - The federal judge presiding over the NuvaRing multidistrict litigation on Aug. 11 denied the manufacturers' request for plaintiffs to share the costs of producing electronically stored information after finding that the companies failed to establish that they have been subject to any more burdensome or expensive discovery than is normally incurred in complex litigation cases (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 13 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 14%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>NuvaRing MDL Judge Schedules Science Day Presentations For Dec. 1</title>
<description>
<![CDATA[ST. LOUIS - On Dec. 1, attorneys and experts in the NuvaRing multidistrict litigation will hold educational presentations explaining the types of injuries allegedly caused by use of the hormonal contraceptive device, the effect the combination of hormones in the product has when administered and the terminology used to discuss the product and its injuries, a federal judge in Missouri ruled July 22 (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.; See March 2009, Page 13). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 14 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-1 Mealeys Hormone Replacement Therapy 15%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>New Judge Named To Preside Over New Jersey Ortho Evra Mass Tort</title>
<description>
<![CDATA[TRENTON, N.J. - A new judge will preside over New Jersey's Ortho Evra mass tort proceedings beginning Sept. 1, according to a notice to the bar signed Aug. 7 by the chief justice of the New Jersey Supreme Court (In re: Ortho Evra Birth Control Patch Litigation, Case No. 275, N.J. Super., Middlesex Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-1 Mealey's Hormone Replacement Therapy 15 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>

</channel>

</rss>